Primary Nav Button
GO

  • PRODUCT AVAILABILITY: Did you know you can view a product's availability right on the product page? Simply enter the quantity you want to purchase and the current availability will appear below the item.

  • Product is restricted and can only be purchased by customers with a web profile linked to a Thomas Business Account - Click here to login or create your web profile. If you do not have a Thomas Business Account, please Contact Us and someone will respond with details on how to apply for a business account with us.

MilliporeSigma

SILu(TM)Lite SigmaMAb Nivolumab Monoclonal Antibody recombinant, expressed in CHO cells

Not yet rated

SILu(TM)Lite SigmaMAb Nivolumab Monoclonal Antibody recombinant, expressed in CHO cells

SigmaMAb Nivolumab (MSQC26) was designed to be a standard for the analysis of Nivolumab monoclonal antibodies using mass spectrometry. An isotopically labeled version is available as SILu(TM)Mab Nivolumab (MSQC27). SigmaMAb Nivolumab is for research use only and is not intended for diagnostic or therapeutic use.

Synonyms: Biologic Antibody Mimic; Biotherapeutic Antibody Mimic; Monoclonal Antibody Calibrator

Purity: >=90% (HPLC)

Storage: -20C

Legal Information: SILu is a trademark of Sigma-Aldrich Co. LLC

Please Enter Your Order Info

Filter by:

  • Clear Filters
Product Detail
Thomas No.
CHM02L053
Mfr. No.
MSQC26-0.5MG
Description
MSQC26-0.5MG, SILu(TM)Lite SigmaMAb Nivolumab Monoclonal Antibody recombinant, expressed in CHO cells
Packaging Size
0.5 mg
list price/quantitytotal
$0.00
$0.00 (0 Items)
Product is restricted and can only be purchased by customers with a web profile linked to a Thomas Business Account - Click here to login or create your web profile. If you do not have a Thomas Business Account, please Contact Us and someone will respond with details on how to apply for a business account with us.

May we suggest

Write A Review

Submit Review
Cancel
Back To Top

About

Resources

Support

Shopping Tools

ISO 9001:2015 Certified Company

©Thomas Scientific 2024 All Rights Reserved. Terms & Conditions